Literature DB >> 11908633

Bovine lactoferrin and lactoferricin derived from milk: production and applications.

M Tomita1, H Wakabayashi, K Yamauchi, S Teraguchi, H Hayasawa.   

Abstract

Bovine lactoferrin is produced on an industrial scale from cheese whey or skim milk. The safety of purified lactoferrin has been confirmed from the results of a reverse mutation test using bacteria, a 13-week oral repeated-dose toxicity study in rats, and clinical studies. In order to apply active lactoferrin to various products, a process for its pasteurization was developed. Subsequently, lactoferrin has been used in a wide variety of products since it was first added to infant formula in 1986. A pepsin hydrolysate of lactoferrin is also used in infant formula. This hydrolysate contains a potent antimicrobial peptide named lactoferricin that is derived from the lactoferrin molecule by pepsin digestion. Semilarge-scale purification of lactoferricin can be performed by hydrophobic interaction chromatography. Lactoferricin also exhibits several biological actions and appears to be the functional domain of lactoferrin. Recent studies have demonstrated that oral administration of lactoferrin or lactoferricin exerts a host-protective effect in various animals and in humans. The results of these studies strongly suggest that the effects of oral lactoferrin are mediated by modulation of the immune system. Further elucidation of the clinical efficacy and mechanism of action of lactoferrin will increase the value of lactoferrin-containing products.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11908633     DOI: 10.1139/o01-230

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  26 in total

1.  Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer.

Authors:  Aleksandra M Urbanska; Emmanouil D Karagiannis; Gonzalo Guajardo; Robert S Langer; Daniel G Anderson
Journal:  Biomaterials       Date:  2012-04-01       Impact factor: 12.479

2.  Hydrolytic breakdown of lactoferricin by lactic acid bacteria.

Authors:  Moushumi Paul; George A Somkuti
Journal:  J Ind Microbiol Biotechnol       Date:  2009-11-19       Impact factor: 3.346

3.  Amoebicidal activity of milk, apo-lactoferrin, sIgA and lysozyme.

Authors:  Nidia León-Sicairos; Fernando López-Soto; Magda Reyes-López; Delfino Godínez-Vargas; Cynthia Ordaz-Pichardo; Mireya de la Garza
Journal:  Clin Med Res       Date:  2006-06

4.  Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children.

Authors:  Theresa J Ochoa; Elsa Chea-Woo; Nelly Baiocchi; Iris Pecho; Miguel Campos; Ana Prada; Gladys Valdiviezo; Angela Lluque; Dejian Lai; Thomas G Cleary
Journal:  J Pediatr       Date:  2012-08-30       Impact factor: 4.406

5.  Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates.

Authors:  Mohan Pammi; Steven A Abrams
Journal:  Cochrane Database Syst Rev       Date:  2019-05-11

Review 6.  Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants.

Authors:  Mohan Pammi; Gautham Suresh
Journal:  Cochrane Database Syst Rev       Date:  2017-06-28

7.  Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia.

Authors:  Hiroyuki Wakabayashi; Koji Yamauchi; Tetsuo Kobayashi; Tomoko Yaeshima; Keiji Iwatsuki; Hiromasa Yoshie
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

8.  TGF-β2, a protective intestinal cytokine, is abundant in maternal human milk and human-derived fortifiers but not in donor human milk.

Authors:  Aaron A Reeves; Marney C Johnson; Margarita M Vasquez; Akhil Maheshwari; Cynthia L Blanco
Journal:  Breastfeed Med       Date:  2013-07-19       Impact factor: 1.817

9.  Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin.

Authors:  Hiroyuki Wakabayashi; Natsuko Takakura; Koji Yamauchi; Yoshitaka Tamura
Journal:  Clin Vaccine Immunol       Date:  2006-02

10.  MNN5 encodes an iron-regulated alpha-1,2-mannosyltransferase important for protein glycosylation, cell wall integrity, morphogenesis, and virulence in Candida albicans.

Authors:  Chen Bai; Xiao-Li Xu; Fong-Yee Chan; Raymond Teck Ho Lee; Yue Wang
Journal:  Eukaryot Cell       Date:  2006-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.